ADMA Biologics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
15,527.20
16,813.20
17,969.90
19,515.20
43,759.00
65,743.40
Depreciation, Depletion & Amortization
210.60
247.90
469.80
469.60
2,692.30
3,446.40
Other Funds
-
-
132.50
-
1,790.00
3,306.80
Funds from Operations
12,053.90
14,882.80
14,747.30
17,261.40
36,989.50
58,990.20
Changes in Working Capital
1,166.70
177.90
671.10
1,007.60
282.20
3,688.40
Net Operating Cash Flow
10,887.20
14,704.90
15,418.40
18,269.00
37,271.80
62,678.70
Capital Expenditures
196.60
2,323.30
26.10
73.40
2,676.30
Sale of Fixed Assets & Businesses
-
-
-
-
12,500.00
Purchase/Sale of Investments
2,935.20
1,717.50
1,715.50
978.00
5,390.20
Net Investing Cash Flow
3,131.80
4,040.70
1,741.60
904.60
15,213.90
Issuance/Reduction of Debt, Net
988.40
9,807.20
227.80
3,937.80
23,333.30
Net Financing Cash Flow
27,632.80
9,795.20
10,401.90
16,838.30
60,750.60
Net Change in Cash
13,613.80
8,950.40
6,758.10
526.10
38,692.70
Free Cash Flow
11,083.80
17,028.20
15,444.50
18,342.40
39,948.10
Change in Capital Stock
26,644.30
12.00
10,306.60
12,900.50
39,207.40
About ADMA Biologics
View Profile
